No Detail Found!

Baseline keratin-18 level and risk of anti-tuberculosis drug-induced liver injury: An individual matched case-control study

Author(s)
Bing Han Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University,Nanjing,China
Min Zhu Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University,Nanjing,China
Yiwen He Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University,Nanjing,China
Meiling Zhang Department of Infectious Disease, The Jurong Hospital Affiliated to Jiangsu University,Jurong,China
Lihuan Lu Department of Tuberculosis, The Second People's Hospital of Changshu,Changshu,China
Hongqiu Pan Department of Tuberculosis, The Third People's Hospital of Zhenjiang Affiliated to Jiangsu University,Zhenjiang,China
Xiaomin He Department of Infectious Disease, The People's Hospital of Taixing,Taixing,China
Honggang Yi Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University,Nanjing,China
Shaowen Tang Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University,Nanjing,China
Abstract
Anti-tuberculosis drug-induced liver injury (ATLI) presents a grand challenge to the global control of tuberculosis. Serum keratin-18 may have a certain predictive value for the occurrence of liver injury. The purpose of this study is to examine the correlation between baseline serum keratin-18 levels and ATLI risk among the eastern Chinese Han population. Employing a 1:2 individual matched case-control approach, the study encompassed 88 ATLI cases and 176 controls. Univariate and multivariate conditional logistic regression analyses were performed to evaluate the association between baseline keratin-18 levels and ATLI risk. Furthermore, area under the curve (AUC) was used to assess keratin18's efficacy in distinguishing ATLI cases from controls. In ATLI cases, baseline keratin-18 levels were significantly lower than controls (188.8 vs. 234.9 ng/L, P = 0.044), with higher levels associated with reduced ATLI risk (OR = 0.995, 95% CI: 0.992-0.999, P = 0.005). Under the optimal keratin-18 cut-off value of 191.6 ng/L, the AUCs were equal to 0.577 (95% CI: 0.513-0.640, P = 0.018) in univariate analysis and 0.597 (95% CI: 0.524-0.670, P = 0.010) in multivariate analysis. The present study indicated that the higher the baseline keratin-18 concentration in tuberculosis patients of eastern Chinese Han population, the lower the risk of ATLI.
Publication Details
Page(s) 751-758
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 38, Issue: 3, Year: 2025

Request the full text from PASTIC

Keywords
Anti-tuberculosis drug-induced liver injury, individual matched case-control study, keratin-18
References
Bagcchi S .2023 .. WHO's Global Tuberculosis Report 2022. Lancet Microbe, 4(1) : e20.
Bowers A,Zhou X .2019 .Receiver Operating Characteristic (ROC) Area Under the Curve (AUC): A diagnostic measure for evaluating the accuracy of predictors of education outcomes. J. Educ. Stu. Placed Risk, 24(1) : 20-46.
Cheng X,Zhu J,Li Y,Luo W,Xiang H,Zhang Q,Peng W .2022 .Serum biomarkers of isoniazidinduced liver injury: Aminotransferases are insufficient and OPN, L-FABP and HMGB1 can be promising novel biomarkers. J. Appl. Toxicol., 42(3) : 516-528.
Clinton J,Kiparizoska S,Lewis J .2021 .Druginduced liver injury: Highlights and controversies in the recent literature. Drug saf., 44(11) : 1125-1149.
Dear J,Clarke J,Allen L J .2018 .Risk stratification after paracetamol overdose using mechanistic biomarkers: results from two prospective cohort studies. Lancet Gastroenterol. Hepatol., 3(2) : 104-113.
Furin J,Cox H,Pai M H .2019 .. Tuberculosis. Lancet, 393(10181) : 1642-1656.
Guldiken N,Usachov V,Levada K,Trautwein C,Ziol M,Nahon P,Strnad P .2015 .Keratins 8 and 18 are type II acute-phase responsive genes overexpressed in human liver disease. Liver Int, 35(4) : 1203-1212.
Guldiken N,Zhou Q,Rehm M .2015 .Human keratin 8 variants promote mouse acetaminophen hepatotoxicity co upled with c-jun amino-terminal kinase activation and protein adduct formation. Hepatology, 62(3) : 876-886.
Harada M,Strnad P,Resurreccion E,Ku N,Omary M .2007 .Keratin 18 overexpression but not phosphorylation or filament organization blocks mouse Mallory body formation. Hepatology, 45 : 88-96.
Howell L,Ireland L,Park B,Goldring C B .2018 .MiR122 and other microRNAs as potential circulating biomarkers of dru g-induced liver injury. Expert Rev. Mol. Diag, 18(1) : 47-54.
Kobayashi T,Iwaki M,Yoneda M M,Clin M .2023 .Epidemiology and management of drug-induced liver Injury: Importance of the Updated RUCAM. , 11(5) : 1239-1245.
Korver S,Bowen J,Pearson K,Gonzalez R,French N,Park K,Jenkins R,French N R .2021 .The application of cytokeratin-18 as a biomarker for druginduced liver injury. Arch. Toxicol., 95(11) : 3435-3448.
Lewis J,Korkmaz S,Copeland M .2024 .Diagnosis, prevention and risk-management of drug-induced liver injury due to medications used to treat Mycobacterium tuberculosis. Expert Opin, 23(9) : 1093-1107.
Lim Y,Ku N Y .2021 .Revealing the roles of keratin 8/18-associated signaling proteins involved in the development of hepatocellular carcinoma. Int. J. Mol. Sci, 22(12) : 6401.
Omary M,Ku N,Toivola D .2002 .Keratins: guardians of the liver. Hepatology, 35(2) : 251-257.
Qian H and Ding W .2023 .SQSTM1/p62 and hepatic mallory-denk body formation in alcohol-associated Liver Disease. Am. J. Pathol., 193(10) : 1415-1426.
Ravindra K,Vaidya V,Wang Z,Ramaiah S Z .2023 .Tandem mass tag-based quantitative proteomic profiling identifies cand idate serum biomarkers of drug-induced liver injury in humans. Nat. commun., 14(1) : 1215.
Rupprechter S,Sloan D,Oosthuyzen W,Bachmann T,Hill A,Dhaliwal K,Templeton K,Matovu J,Sekaggya W,Bachmann T .2021 .MicroRNA-122 and cytokeratin-18 have potential as a biomarkers of druginduced liver injury in European and African patients on treatment for mycobacterial infection. Br. J. Clin. Pharmacol, 87(8) : 3206-3217.
Singampalli K,Li J,Lillehoj P .2022 .Rapid magneto-enzyme-linked immunosorbent assay for ultrasensitive protein detection. Anal. Chim. Acta, 1225 : 340246.
Suárez I,Funger S,Kröger S,Rademacher J,Fätkenheuer G,Rybniker J .2019 .The Diagnosis and Treatment of Tuberculosis. , 116(43) : 729-735.
Tajima S,Yamamoto N,Masuda S N .2019 .Clinical prospects of biomarkers for the early detection and/or prediction of organ injury associated with pharmacotherapy. Biochem. Pharmacol., 170 : 113664.
Tamber S,Bansal P,Sharma R .2023 .Biomarkers of liver diseases. Mol. Biol. Rep, 50(9) : 7815-7823.
Thulin P,Nordahl G,Aklillu E .2014 .Keratin-18 and microRNA-122 complement alanine aminotransferase as nov el safety biomarkers for drug-induced liver injury in two human cohorts. Liver Int, 34(3) : 367-378.
Tostmann A,Boeree M,Dekhuijzen R M .2008 .Antituberculosis drug-induced hepatotoxicity: Concise up-to-date review. J. Gastroenterol. Hepatol., 23(2) : 192-202.
Wang B,Yang W,Meyers M .2016 .Keratin: Structure, mechanical properties, occurrence in biological organisms, and efforts at bioinspiration. Prog. Mater. Sci., 76 : 229-318.
Wang P,Chen Y,Fan H Y .2021 .Keratin 18 induces proliferation, migration and invasion in gastric cancer via the MAPK signalling pathway. Clin. Exp. Pharmacol. Physiol., 48(1) : 147-156.
Wu Y,Zhou J,Li H J .2024 .Cytokeratin 18 in nonalcoholic fatty liver disease: value and application. Expert Rev. Mol. Diagn, 24(11) : 1009-1022.
Xiang H,Li Y,Cheng X,He B,Li H,Zhang Q,Wang B,Zhang Q .2023 .Serum levels of IL-6/IL10/GLDH may be early recognition markers of antituberculosis drugs (ATB)-induced liver injury. Toxicol. Appl, 475 : 116635.
Yu Y,Mao Y,Cong W Y .2017 .CSH guidelines for the diagnosis and treatment of drug-induced liver injury. Hepatol. Int., 11(3) : 221-241.
0

Citations

0

Downloads

75

Views